Back
Raia Drogasil SA Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
49
RADLY
Raia Drogasil SA
Last Price:
4.90
Seasonality Move:
7.35%
Buy
59
NBY
NovaBay Pharmaceuticals
Last Price:
0.14
Seasonality Move:
-0.33%
Sell
49
Raia Drogasil SA (RADLY)
is a Sell
Is Raia Drogasil SA a Buy, Sell or Hold?
- The current Raia Drogasil SA [RADLY] share price is $4.90. The Score for RADLY is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- RADLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
NovaBay Pharmaceuticals (NBY)
is a Buy
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.17. The Score for NBY is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- NBY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RADLY Stock Price Chart
What is Raia Drogasil SA's stock price today?
-
The Raia Drogasil SA share price today is $4.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RADLY is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.17
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight selling pressure.
RADLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 45 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.85 - 5.31) | Sell |
| Bollinger Bands (100): | (5 - 6.62) | Sell |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 81.56 | Buy |
| Chaikin Money Flow: | -17264309 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.07 - 0.11) | Buy |
| Bollinger Bands (100): | (0.09 - 0.17) | Buy |
RADLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.08 | Sell |
| 20-day SMA: | 5.1 | Sell |
| 50-day SMA: | 5.27 | Sell |
| 200-day SMA: | 5.66 | Sell |
| 8-day EMA: | 5.05 | Sell |
| 20-day EMA: | 5.1 | Sell |
| 50-day EMA: | 5.3 | Sell |
| 200-day EMA: | 5.61 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.11 | Buy |
| 20-day SMA: | 0.09 | Buy |
| 50-day SMA: | 0.1 | Buy |
| 200-day SMA: | 0.28 | Sell |
| 8-day EMA: | 0.12 | Buy |
| 20-day EMA: | 0.1 | Buy |
| 50-day EMA: | 0.11 | Buy |
| 200-day EMA: | 0.5 | Sell |
Raia Drogasil SA Earnings Growth & RADLY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.06 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Raia Drogasil SA Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||